- Home
- MET vs COR Comparison
MET vs COR Comparison
Compare MET & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MET
- COR
- Stock Information
- Founded
- MET 1863
- COR 2001
- Country
- MET United States
- COR United States
- Employees
- MET N/A
- COR N/A
- Industry
- MET Life Insurance
- COR Other Pharmaceuticals
- Sector
- MET Finance
- COR Health Care
- Exchange
- MET Nasdaq
- COR Nasdaq
- Market Cap
- MET 49.7B
- COR 55.0B
- IPO Year
- MET N/A
- COR N/A
- Fundamental
- Price
- MET $81.49
- COR $292.44
- Analyst Decision
- MET Strong Buy
- COR Buy
- Analyst Count
- MET 10
- COR 12
- Target Price
- MET $95.60
- COR $308.83
- AVG Volume (30 Days)
- MET 3.6M
- COR 1.4M
- Earning Date
- MET 08-06-2025
- COR 08-06-2025
- Dividend Yield
- MET 2.79%
- COR 0.75%
- EPS Growth
- MET 61.27
- COR 5.07
- EPS
- MET 5.93
- COR 9.68
- Revenue
- MET $73,011,000,000.00
- COR $316,654,371,000.00
- Revenue This Year
- MET $7.25
- COR $10.48
- Revenue Next Year
- MET $3.69
- COR $6.78
- P/E Ratio
- MET $13.75
- COR $30.20
- Revenue Growth
- MET 6.17
- COR 11.56
- 52 Week Low
- MET $65.21
- COR $218.65
- 52 Week High
- MET $89.05
- COR $309.35
- Technical
- Relative Strength Index (RSI)
- MET 65.45
- COR 49.72
- Support Level
- MET $78.46
- COR $288.32
- Resistance Level
- MET $78.33
- COR $306.28
- Average True Range (ATR)
- MET 1.55
- COR 7.83
- MACD
- MET 0.61
- COR 1.19
- Stochastic Oscillator
- MET 95.72
- COR 57.87
About MET MetLife Inc.
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.